Perrotta Kirstie, Harris-Sagaribay Lorrie, Bandoli Gretchen
MotherToBaby California, University of California San Diego, La Jolla, California, USA.
MotherToBaby North Carolina, University of North Carolina at Chapel Hill, Asheville, North Carolina, USA.
Birth Defects Res. 2025 Apr;117(4):e2477. doi: 10.1002/bdr2.2477.
When coronavirus disease 2019 (COVID-19) vaccines first became available, pregnancy and lactation data were lacking. This void was often filled by misinformation. Even as data about pregnancy outcomes following COVID-19 vaccination began to emerge, the public was often unsure how to interpret the information, and many pregnant women remained unclear on whether to get vaccinated. MotherToBaby and Centers for Disease Control and Prevention (CDC) quickly partnered to direct the public to MotherToBaby, a nationwide teratogen information service, for free and confidential discussions about COVID-19 vaccines in pregnancy and lactation. This paper describes the partnership between MotherToBaby and CDC and the resulting COVID-19 vaccine inquiries received.
Aggregate, deidentified data were extracted from a centralized database utilized by MotherToBaby to capture information about exposure inquiries. The data include exposure topics, caller characteristics, and specific questions about COVID-19 vaccination.
Between March 1, 2021 and February 28, 2023, MotherToBaby answered 11,064 questions about COVID-19 vaccines. Most (68.5%) were related to vaccine safety, with common safety-related themes including perceived haste in vaccine development, hesitancy about mRNA technology, and concerns about infertility, miscarriage, and long-term effects on the child. Lessons learned include the essential role of partnerships to educate the public during emergencies, the importance of building staff capacity during nonemergency times, and the need for one-on-one conversations to counter vaccine misinformation.
During the COVID-19 pandemic, MotherToBaby met a critical need by providing individualized, evidence-based information to the public. During future public health emergencies, teratogen information services are uniquely suited to provide unbiased information about the risks and benefits of vaccines and other exposures.
2019年冠状病毒病(COVID-19)疫苗首次上市时,缺乏关于妊娠和哺乳期的数据。这一空白常常被错误信息所填补。即使关于COVID-19疫苗接种后妊娠结局的数据开始出现,公众往往也不确定如何解读这些信息,许多孕妇仍不清楚是否要接种疫苗。母婴健康热线(MotherToBaby)和疾病控制与预防中心(CDC)迅速合作,引导公众前往母婴健康热线,这是一项全国性的致畸物信息服务,以便就妊娠和哺乳期的COVID-19疫苗进行免费且保密的讨论。本文描述了母婴健康热线与疾病控制与预防中心之间的合作以及由此收到的关于COVID-19疫苗的咨询情况。
从母婴健康热线用于收集暴露咨询信息的中央数据库中提取汇总的、去识别化的数据。这些数据包括暴露主题、来电者特征以及关于COVID-19疫苗接种的具体问题。
在2021年3月1日至2023年2月28日期间,母婴健康热线回答了11,064个关于COVID-19疫苗的问题。大多数(68.5%)与疫苗安全性有关,常见的安全相关主题包括认为疫苗研发仓促、对mRNA技术的犹豫以及对不孕、流产和对孩子长期影响的担忧。吸取的经验教训包括在紧急情况下伙伴关系对公众教育的重要作用、在非紧急时期建设工作人员能力的重要性以及一对一谈话以对抗疫苗错误信息的必要性。
在COVID-19大流行期间,母婴健康热线通过向公众提供个性化的、基于证据的信息满足了一项关键需求。在未来的公共卫生紧急事件中,致畸物信息服务特别适合提供关于疫苗和其他暴露的风险与益处的无偏见信息。